Literature DB >> 36073700

Tolerability and efficacy of paroxetine and naltrexone for treatment of compulsive sexual behaviour disorder.

Michał Lew-Starowicz1, Małgorzata Draps2, Ewelina Kowalewska1, Katarzyna Obarska2, Shane W Kraus3, Mateusz Gola2,4.   

Abstract

Entities:  

Year:  2022        PMID： 36073700      PMCID： PMC9453901          DOI： 10.1002/wps.21026

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   79.683


× No keyword cloud information.
  5 in total

1.  Current pharmacotherapy for gambling disorder: a systematic review.

Authors:  Shane W Kraus; Repairer Etuk; Marc N Potenza
Journal:  Expert Opin Pharmacother       Date:  2020-01-11       Impact factor: 3.889

2.  Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis.

Authors:  I M Anderson; B M Tomenson
Journal:  BMJ       Date:  1995-06-03

3.  Emerging experience with selected new categories in the ICD-11: complex PTSD, prolonged grief disorder, gaming disorder, and compulsive sexual behaviour disorder.

Authors:  Geoffrey M Reed; Michael B First; Joël Billieux; Marylene Cloitre; Peer Briken; Sophia Achab; Chris R Brewin; Daniel L King; Shane W Kraus; Richard A Bryant
Journal:  World Psychiatry       Date:  2022-06       Impact factor: 79.683

Review 4.  Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.

Authors:  Carmen Bouza; Magro Angeles; Angeles Magro; Ana Muñoz; José María Amate
Journal:  Addiction       Date:  2004-07       Impact factor: 6.526

5.  Naltrexone in Compulsive Sexual Behavior Disorder: A Feasibility Study of Twenty Men.

Authors:  Josephine Savard; Katarina Görts Öberg; Andreas Chatzittofis; Cecilia Dhejne; Stefan Arver; Jussi Jokinen
Journal:  J Sex Med       Date:  2020-06-10       Impact factor: 3.802
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.